Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia

Journal of Pediatrics

Volumn 129, Issue 4, 1996, Pages 551-558

  Bernini, J C ^a   Wooley, R ^a   Buchanan, G R ^a  

^a SOUTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE ACTIVITY; DOSE RESPONSE; FOLLOW UP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NEUTROPENIA; PATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT PLANNING;

EID: 0030357629     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70120-8     Document Type: Article

References (32)

1. DC Dale MA Bonilla MW Davis A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia Blood 81 1993 2496 2502
2. K Welte C Zeidler A Reiter Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia Blood 75 1990 1056 1063
3. AM Bonilla AP Gillio M Ruggeiro Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis N Engl J Med 320 1989 1574 1580
4. JA Glaspy The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia Oncol Nurs Forum 18 1991 1411 1414
5. JE Bolyard D Dale Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony stimulating factor JAMA 270 1993 1132 1133
6. S Imashuku M Tsuchida M Sasaki Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with chronic benign granulocytopenia and congenital agranulocytosis (Kostmann's syndrome) Acta Paediatr 81 1992 133 136
7. J Bux C Muller-Eckhardt Autoimmune neutropenia Semin Hematol 29 1992 45 53
8. OG Jonsson GR Buchanan Chronic neutropenia of childhood Arch Pediatr Adolesc Med [Am J Dis Child] 145 1991 232 235
9. KA Shastri GL Logue Autoimmune neutropenia Blood 81 1993 1984 1995
10. KR Hartman VF LaRussa SW Rothwell TO Atolagbe FT Ward G Klippe Antibodies to myeloid precursor cells in autoimmune neutropenia Blood 84 1994 625 631
11. IJ Dunkel JB Bussel New developments in the treatment of neutropenia Arch Pediatr Adolesc Med [Am J Dis Child] 147 1993 994 1000
12. J Bussel P Lalezari S Fikring Intravenous treatment with gammaglobulin of autoimmune neutropenia of infancy J Pediatr 112 1988 298 301
13. LA Boxer MS Greenberg GJ Boxer TP Stossel Autoimmune neutropenia N Engl J Med 293 1975 748 753
14. DK Sinsabaugh DR Freyer Big cost savings from small filgrastim doses [letter] Am J Hosp Pharm 50 1993 1363 1364
15. CR DiPiro Filgrastim doses should not be standardized for pediatric patients [letter] Am J Hosp Pharm 50 1993 447
16. MH Bronchoud JH Scarffe N Thatcher Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer Br J Cancer 56 1987 809 813
17. G Morstyn L Campell LM Souza Effects of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy Lancet 1 1988 667 672
18. JL Gabrilove A Jakobowski H Scher Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium N Engl J Med 318 1988 1414 1422
19. HA Jakubowski L Souza F Kelly Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia N Engl J Med 320 1989 38 42
20. S Jayabose O Tugal C Sandoval K Li Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: use of a new 3-day-a-week regimen Am J Pediatr Hematol Oncol 16 1994 338 340
21. G Toner A Woollet C Laidlaw Low versus standard dose G-CSF prophylaxis after chemotherapy: a randomized, crossover comparison [abstract] Proc Am Soc Clin Oncol 13 1994 429A
22. P Wallace D Colley A Chrusoskie Experience with a pharmacy based monitoring service [abstract] Proc Am Soc Clin Oncol 13 1994 433A
23. RS Kaczmarski GJ Mufti Low-dose filgrastim therapy for chronic neutropenia N Engl J Med 329 1993 1280 1281
24. RS Kaczmarski A Pozniak A Lakhani E Harvey GJ Mufti A pilot study of low-dose recombinant human granulocyte macrophage colony-stimulating factor in chronic neutropenia Br J Haematol 84 1993 338 340
25. A Ganser OG Ottmann H Erdmann G Schulz D Hoelzer The effect of recombinant human granulocyte-macrophage colony stimulating factor on neutropenia and related morbidity in chronic severe neutropenia Ann Intern Med 111 1989 887 892
26. K Takahashi S Tanigushi K Akashi Human recombinant granulocyte colony-stimulating factor for the treatment of autoimmune neutropenia Acta Haematol 86 1991 95 98
27. CM Kearns WC Wang N Stute JN Ihle WE Evan Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia J Pediatr 123 1993 471 479
28. U Kyas T Pietsch K Welte Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia Blood 79 1992 1144 1147
29. JM Kerst M de Haas CE van der Schoot Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells Blood 82 1993 3265 3272
30. E Roilides TJ Walsh PA Pizzo M Rubin Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils J Infect Dis 163 1991 579 583
31. J Bux JO Dickmann C Muller-Eckhardt Influence of human granulocyte-specific antibodies on granulocyte function [abstract] Blood 76 1990 382A
32. LA Boxer TP Stossel Effects of anti-human neutrophil antibodies in vitro: quantitative studies J Clin Invest 53 1974 1534 1545